Response to 6 cycles of chemotherapy with FOLFIRINOX is predictive of overall survival in patients with locally advanced unresectable pancreatic cancer

Haderlein M, Lubgan D, Lettmaier S, Semrau S, Wolf W, Golcher H, Hohenberger W, Fietkau R (2016)

Publication Type: Conference contribution

Publication year: 2016

Journal

Oncology Research and Treatment Karger Publishers

Book Volume: 39

Pages Range: 15-15

Authors with CRIS profile

Marlen Haderlein Department of Radiation Oncology Dorota Lubgan Department of Radiation Oncology Werner Hohenberger Department of Surgery Rainer Fietkau Lehrstuhl für Strahlentherapie

How to cite

APA:

Haderlein, M., Lubgan, D., Lettmaier, S., Semrau, S., Wolf, W., Golcher, H.,... Fietkau, R. (2016). Response to 6 cycles of chemotherapy with FOLFIRINOX is predictive of overall survival in patients with locally advanced unresectable pancreatic cancer. (pp. 15-15).

MLA:

Haderlein, Marlen, et al. "Response to 6 cycles of chemotherapy with FOLFIRINOX is predictive of overall survival in patients with locally advanced unresectable pancreatic cancer." 2016. 15-15.

BibTeX: Download